Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase III trial of Procysteine i.v. suspended

March 23, 1998

Mochida describes new antiasthma agent with novel profile

March 23, 1998

L-0066: a novel inhibitor of PDE IV and mediator release in vitro

March 23, 1998

Synergistic effects of montelukast and loratadine in allergic patients

March 23, 1998

Antiasthma effects of first-generation Primatized anti-CD4 MAb studied in patients

March 23, 1998

Antioxidant properties of DHLA suggest future therapeutic applications

March 23, 1998

Faes reveals new antihistamines

March 18, 1998

Indazole inhibitors of PDE IV and TNF from Pfizer

March 18, 1998

Merck & Co. obtains improved analogues of montelukast

March 17, 1998

Nuvance stabilizes lung function in asthmatic patients

March 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...